PEDIATRICS Vol. 72 No. 1 July 1983, pp. 60-64
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, D. E.
Right arrow Articles by König, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, D. E.
Right arrow Articles by König, P.

Effect of Inhaled Beclomethasone Dipropionate on Hypothalamic-Pituitary-Adrenal Axis Function in Children with Asthma

David E. Goldstein MD1 and Peter König MD, PhD1

1 From the Department of Child Health, University of Missouri, Columbia

The hypothalamic-pituitary-adrenal axis was investigated in 15 asthmatic children treated with inhaled beclomethasone dipropionate (mean 490 µg/day) and 11 asthmatic control subjects receiving no corticosteroid therapy. Measurements of 24-h urinary free cortisol and 17 hydroxy corticosteroids, serum cortisol, response to ACTH, and the oral metyrapone test showed no significant difference between the two groups. All the patients' results were within normal limits, and carbohydrate metabolism, as shown by blood glucose and hemoglobin A1c, was not affected by beclomethasone therapy. Thus, in the above dose, inhaled beclomethasone does not cause suppression of the hypothalamic--pituitary-adrenal axis.

Key Words: beclomethasone dipropionate • asthma • hypothalamic-pituitaryadrenal function testing

Submitted on August 2, 1982




This article has been cited by other articles:


Home page
 EndocrinologyHome page
G. Abraham, J. Gottschalk, and F. R. Ungemach
Evidence for Ototopical Glucocorticoid-Induced Decrease in Hypothalamic-Pituitary-Adrenal Axis Response and Liver Function
Endocrinology, July 1, 2005; 146(7): 3163 - 3171.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. B. Bacharier, H. H. Raissy, L. Wilson, B. McWilliams, R. C. Strunk, and H. W. Kelly
Long-Term Effect of Budesonide on Hypothalamic-Pituitary-Adrenal Axis Function in Children With Mild to Moderate Asthma
Pediatrics, June 1, 2004; 113(6): 1693 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. W. Georgitis
The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of Asthma
Chest, January 1, 1999; 115(1): 210 - 217.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
D. Fitzgerald, P. Van Asperen, C. Mellis, M. Honner, L. Smith, and G. Ambler
Fluticasone propionate 750 µg/day versus beclomethasone dipropionate 1500 µg/day: comparison of efficacy and adrenal function in paediatric asthma
Thorax, August 1, 1998; 53(8): 656 - 661.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child.Home page
P. K Yiallouros, A. D Milner, E. Conway, and J. W Honour
Adrenal function and high dose inhaled corticosteroids for asthma
Arch. Dis. Child., May 1, 1997; 76(5): 405 - 410.
[Abstract] [Full Text]

Home page
 NEJMHome page
B. Volovitz, J. Amir, H. Malik, A. Kauschansky, and I. Varsano
Growth and Pituitary-Adrenal Function in Children with Severe Asthma Treated with Inhaled Budesonide
N. Engl. J. Med., December 2, 1993; 329(23): 1703 - 1708.
[Abstract] [Full Text]